These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7039285)

  • 1. Vasodilator therapy: implications in acute myocardial infarction and congestive heart failure.
    Cohn JN
    Am Heart J; 1982 Apr; 103(4 Pt 2):773-8. PubMed ID: 7039285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure.
    Chatterjee K; Parmley WW
    J Am Coll Cardiol; 1983 Jan; 1(1):133-53. PubMed ID: 6338075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
    Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L
    Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vasodilator treatment of left ventricular insufficiency in the acute stage of myocardial infarction].
    Fauvel JM; Donzeau JP; Bounhoure JP; Bernadet P; Calazel P
    Arch Mal Coeur Vaiss; 1977 Aug; 70(8):825-32. PubMed ID: 409363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic guidelines in the treatment of acute myocardial infarction by means of vasodilators].
    Zilcher H
    Acta Med Austriaca Suppl; 1979; 15():1-34. PubMed ID: 161946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of vasodilator therapy after myocardial infarction.
    Hockings BE; Cope GD; Clarke GM; Taylor RR
    Am J Cardiol; 1981 Aug; 48(2):345-52. PubMed ID: 7023223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiocirculatory actions of trimazosin and sodium nitroprusside in ischemic heart disease.
    Awan NA; Hermanovich J; Vera Z; Amsterdam EA; Mason DT
    Clin Pharmacol Ther; 1982 Mar; 31(3):290-6. PubMed ID: 7060312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term beneficial effects of endralazine, a new arteriolar vasodilator at rest and during exercise capacity in chronic congestive heart failure.
    Quyyumi AA; Wagstaff D; Evans TR
    Am J Cardiol; 1984 Nov; 54(8):1020-4. PubMed ID: 6496323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of flosequinan in patients with acute-onset heart failure complicating acute myocardial infarction.
    Schneeweiss A; Wynne RD; Marmor A
    Jpn Heart J; 1989 Sep; 30(5):627-34. PubMed ID: 2614925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilator therapy for chronic left ventricular failure.
    Kovick RB; Tillisch JH; Berens SC; Bramowitz AD; Shine KI
    Circulation; 1976 Feb; 53(2):322-8. PubMed ID: 812614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
    Wagner GC; Robinson PH
    Prim Care; 1981 Sep; 8(3):467-81. PubMed ID: 6796986
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction.
    Cantelli I; Lolli C; Brunelli A; Bracchetti D
    Am Heart J; 1985 Mar; 109(3 Pt 2):716-9. PubMed ID: 3838410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure.
    Franciosa JA; Cohn JN
    Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Afterload reduction in the management of congestive heart failure following acute myocardial infarction.
    Miller RR; Awan NA; Mason DT
    Adv Cardiol; 1978; 23():173-81. PubMed ID: 345758
    [No Abstract]   [Full Text] [Related]  

  • 17. Usefulness and limitations of vasodilator therapy in the treatment of pump failure complicated by acute myocardial infarction.
    Saito M; Hiramori K; Haze K; Sumiyoshi T; Fukami K; Goto Y
    Jpn Circ J; 1984 Apr; 48(4):340-9. PubMed ID: 6716634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic possibilities and therapy in the acute phase of myocardial infarct].
    Pachinger O
    Wien Med Wochenschr; 1984 Dec; 134(23-24):545-9. PubMed ID: 6442063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peripheral vasodilator agents in cardiology].
    Khomenko VL; Pomerantsev VP; Vasiuk IuA
    Sov Med; 1980; (12):70-5. PubMed ID: 6784251
    [No Abstract]   [Full Text] [Related]  

  • 20. Left ventricular failure complicating acute myocardial infarction--problems and potential of nonthrombolytic therapy.
    Taylor SH
    Cardiology; 1988; 75 Suppl 1():67-89. PubMed ID: 3069218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.